Remote Jobs at Alentis Therapeutics
Alentis Therapeutics
51 - 200 employees
Founded 2019
🧬 Biotechnology
đź’Š Pharmaceuticals
🏥 Healthcare
đź’° $181.4M Series D on 2024-11
Biotechnology • Pharmaceuticals • Healthcare
Alentis Therapeutics is a clinical-stage biotechnology company (headquartered in Allschwil, Switzerland) developing anti-Claudin-1 antibody-drug conjugates (ADCs) and monoclonal antibodies to treat cancer and reverse organ fibrosis. Their pipeline includes clinical candidates such as ADC ALE. P02 for squamous cancers, ALE. P03, and the monoclonal antibody lixudebart (ALE. F02) for fibrosis; they emphasize targeted anti-Claudin-1 modalities to open stiff extracellular matrix, block disease signaling, and selectively kill tumor cells.
📡 We watch Alentis Therapeutics's careers page
Several times a day
how often we check
7
roles posted in the last 30 days
Selected: 🇺🇸 United States – Remote USA.
Is on LinkedIn?
